Hematology - European Medical Journal

Continue

Hematology

Articles
11th December 2014

Inherited Thrombocytopaenias: Beyond the Bleeding

The improvement of molecular biology technologies and the increasing number of researchers interested in inherited thrombocytopaenias (ITs) has led…
1st December 2014

Inherited Bone Marrow Failure Syndromes with Pancytopaenia

Bone marrow failure (BMF) is characterised by a reduction in the effective production of mature erythrocytes, granulocytes, and platelets by the bone…
31st July 2014

Biosimilars in Hematology: Increasing Choice, Expanding Access

Biologicals have revolutionised modern medicine by offering vital therapeutic options to treat or prevent complex, disabling, and life-threatening diseases.
31st July 2014

Next Steps in Front-Line Treatment of Lymphoma: The Road Ahead

Prof Zelenetz opened the symposium on the evolving front-line treatment options for follicular lymphoma (FL) and discussed the potential of novel agents…
31st July 2014

The Multiple Facets of Thrombotic Microangiopathies

The Alexion satellite symposium was introduced by Prof Pier Mannuccio Mannucci who provided an introduction to the history of thrombotic…
31st July 2014

The Standard of Care in Relapsed Refractory CD30+ Lymphoma

CD30-positive (CD30+) lymphomas are a heterogeneous group of hematological malignancies that share the same antigen. Over recent decades, advances…
31st July 2014

Overcoming Immunodeficiency in Chronic Lymphocytic Leukaemia: Current Knowledge and Perspectives

While the standard of care for chronic lymphocytic leukaemia (CLL) leads to high overall response rates and a long progression-free survival, it can be…
31st July 2014

The Role of CD49d in Chronic Lymphocytic Leukaemia: Microenvironmental Interactions and Clinical Relevance

Chronic lymphocytic leukaemia (CLL) is a clinically heterogeneous disease characterised by the accumulation/expansion of a clonal population of…